Image of The use of fondaparinux in pregnancy

LITERATURE

The use of fondaparinux in pregnancy


Venous thromboembolism (VTE) remains a major cause of morbidity and mortality in pregnancy. Although relatively safe, hypersensitivity reactions to low-molecular weight heparins (LMWHs) are frequently seen in pregnant women, with
a reported 20% incidence in this cohort (Bank et al, 2003; Schindewolf et al, 2013). Fondaparinux is a synthetic pentasaccharide
that has been extensively studied in thromboprophylaxis and treatment of VTE and which may be used as an alternative in these circumstances. This study describes the use of fondaparinux in pregnant women who experienced heparin allergy in our institution over an 8-year period.


Availability

Diviti-002Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
British Journal of Haematology, 2015, 168, 757–768
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous